Novo Nordisk (NVO) Shares Up Since Jim Cramer Said He Was A Buyer

Novo Nordisk A/S (NYSE:NVO) is one of Jim Cramer’s Hottest GLP-1 and Weight Loss Stock Picks. Novo Nordisk A/S (NYSE:NVO) is a key player in the weight loss drug industry. The firm made a splash earlier this year when it became the first to secure the FDA’s approval for a weight loss drug pill. With the announcement occurring on December 22nd, Novo Nordisk A/S (NYSE:NVO)’s shares closed 7.3% higher on the 23rd. Since Cramer discussed the firm in April 2025, the shares are up by 44%, while they are down by ...